Hepatitis C Virus Nucleotide Inhibitors PSI-352938 and PSI-353661 Exhibit a Novel Mechanism of Resistance Requiring Multiple Mutations within Replicon RNA

被引:41
作者
Lam, Angela M. [1 ]
Espiritu, Christine [1 ]
Bansal, Shalini [1 ]
Steuer, Holly M. Micolochick [1 ]
Zennou, Veronique [1 ]
Otto, Michael J. [1 ]
Furman, Phillip A. [1 ]
机构
[1] Pharmasset Inc, Princeton, NJ 08540 USA
关键词
IN-VITRO; EFFICIENT REPLICATION; SUBGENOMIC REPLICON; CROSS-RESISTANCE; CELL-CULTURE; POLYMERASE; RIBAVIRIN; HCV; NS3; COMBINATION;
D O I
10.1128/JVI.05639-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
PSI-352938, a cyclic phosphate nucleotide, and PSI-353661, a phosphoramidate nucleotide, are prodrugs of beta-D-2'-deoxy-2'-alpha-fluoro-2'-beta-C-methylguanosine-5'-monophosphate. Both compounds are metabolized to the same active 5'-triphosphate, PSI-352666, which serves as an alternative substrate inhibitor of the NS5B RNA-dependent RNA polymerase during HCV replication. PSI-352938 and PSI-353661 retained full activity against replicons containing the S282T substitution, which confers resistance to certain 2'-substituted nucleoside/nucleotide analogs. PSI-352666 was also similarly active against both wild-type and S282T NS5B polymerases. In order to identify mutations that confer resistance to these compounds, in vitro selection studies were performed using HCV replicon cells. While no resistant genotype 1a or 1b replicons could be selected, cells containing genotype 2a JFH-1 replicons cultured in the presence of PSI-352938 or PSI-353661 developed resistance to both compounds. Sequencing of the NS5B region identified a number of amino acid changes, including S15G, R222Q, C223Y/H, L320I, and V321I. Phenotypic evaluation of these mutations indicated that single amino acid changes were not sufficient to significantly reduce the activity of PSI-352938 and PSI-353661. Instead, a combination of three amino acid changes, S15G/C223H/V321I, was required to confer a high level of resistance. No cross-resistance exists between the 2'-F-2'-C-methylguanosine prodrugs and other classes of HCV inhibitors, including 2'-modified nucleoside/-tide analogs such as PSI-6130, PSI-7977, INX-08189, and IDX-184. Finally, we determined that in genotype 1b replicons, the C223Y/H mutation failed to support replication, and although the A15G/C223H/V321I triple mutation did confer resistance to PSI-352938 and PSI-353661, this mutant replicated at only about 10% efficiency compared to the wild type.
引用
收藏
页码:12334 / 12342
页数:9
相关论文
共 30 条
[1]   Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479 [J].
Ali, Samir ;
Leveque, Vincent ;
Le Pogam, Sophie ;
Ma, Han ;
Philipp, Friederike ;
Inocencio, Nicole ;
Smith, Mark ;
Alker, Andre ;
Kang, Hyunsoon ;
Najera, Isabel ;
Klumpp, Klaus ;
Symons, Julian ;
Cammack, Nick ;
Jiang, Wen-Rong .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (12) :4356-4369
[2]   Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture [J].
Blight, KJ ;
McKeating, JA ;
Marcotrigiano, J ;
Rice, CM .
JOURNAL OF VIROLOGY, 2003, 77 (05) :3181-3190
[3]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[4]   Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661 [J].
Furman, Phillip A. ;
Murakami, Eisuke ;
Niu, Congrong ;
Lam, Angela M. ;
Espiritu, Christine ;
Bansal, Shalini ;
Bao, Haiying ;
Tolstykh, Tatiana ;
Steuer, Holly Micolochick ;
Keilman, Meg ;
Zennou, Veronique ;
Bourne, Nigel ;
Veselenak, Ronald L. ;
Chang, Wonsuk ;
Ross, Bruce S. ;
Du, Jinfa ;
Otto, Michael J. ;
Sofia, Michael J. .
ANTIVIRAL RESEARCH, 2011, 91 (02) :120-132
[5]   Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose [J].
Hadziyannis, SJ ;
Sette, H ;
Morgan, TR ;
Balan, V ;
Diago, M ;
Marcellin, P ;
Ramadori, G ;
Bodenheimer, H ;
Bernstein, D ;
Rizzetto, M ;
Zeuzem, S ;
Pockros, PJ ;
Lin, A ;
Ackrill, AM .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) :346-355
[6]   Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon [J].
Kato, T ;
Date, T ;
Miyamoto, M ;
Furusaka, A ;
Tokushige, K ;
Mizokami, M ;
Wakita, T .
GASTROENTEROLOGY, 2003, 125 (06) :1808-1817
[7]   Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs) [J].
Kieffer, Tara L. ;
Kwong, Ann D. ;
Picchio, Gaston R. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) :202-212
[8]   Resistance mechanisms in HCV: from evolution to intervention [J].
Kim, Arthur Y. ;
Timm, Joerg .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (04) :463-478
[9]   The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells [J].
Koutsoudakis, George ;
Herrmann, Eva ;
Kallis, Stephanie ;
Bartenschlager, Ralf ;
Pietschmann, Thomas .
JOURNAL OF VIROLOGY, 2007, 81 (02) :588-598
[10]   Naturally Occurring Dominant Resistance Mutations to Hepatitis C Virus Protease and Polymerase Inhibitors in Treatment-Naive Patients [J].
Kuntzen, Thomas ;
Timm, Joerg ;
Berical, Andrew ;
Lennon, Niall ;
Berlin, Aaron M. ;
Young, Sarah K. ;
Lee, Bongshin ;
Heckerman, David ;
Carlson, Jonathan ;
Reyor, Laura L. ;
Kleyman, Marianna ;
McMahon, Cory M. ;
Birch, Christopher ;
Wiesch, Julian Schulze zur ;
Ledlie, Timothy ;
Koehrsen, Michael ;
Kodira, Chinnappa ;
Roberts, Andrew D. ;
Lauer, Georg M. ;
Rosen, Hugo R. ;
Bihl, Florian ;
Cerny, Andreas ;
Spengler, Ulrich ;
Liu, Zhimin ;
Kim, Arthr Y. ;
Xing, Yanming ;
Schneidewind, Arne ;
Madey, Margaret A. ;
Fleckenstein, Jaquelyn F. ;
Park, Vicki M. ;
Galagan, James E. ;
Nusbaum, Chad ;
Walker, Bruce D. ;
Lake-Bakaar, Gerond V. ;
Daar, Eric S. ;
Jacobson, Ira M. ;
Gomperts, Edivard D. ;
Edlin, Brian R. ;
Donfield, Sharyne M. ;
Chung, Raymond T. ;
Talal, Andrew H. ;
Marion, Tony ;
Birren, Bruce W. ;
Henn, Mattliew R. ;
Allen, Todd M. .
HEPATOLOGY, 2008, 48 (06) :1769-1778